Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
<br><strong>Background: </strong>Gatifloxacin is used for the treatment of multidrug-resistant tuberculosis (MDR-TB). The optimal dose is unknown.</br> <br><strong>Methods: </strong>We performed a 28-day gatifloxacin hollow-fiber system model of tuberculosi...
Auteurs principaux: | Deshpande, D, Pasipanodya, JG, Srivastava, S, Bendet, P, Koeuth, T, Bhavnani, SM, Ambrose, PG, Smythe, W, McIlleron, H, Thwaites, GE, Gumusboga, M, Van Deun, A, Gumbo, T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Oxford University Press
2018
|
Documents similaires
-
Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis
par: Deshpande, D, et autres
Publié: (2018) -
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
par: Thwaites, G, et autres
Publié: (2011) -
Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis
par: Ding, J, et autres
Publié: (2020) -
Pharmacokinetics of antiretroviral drugs in infancy
par: Helen McIlleron, et autres
Publié: (2009-12-01) -
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis
par: Olliaro, P, et autres
Publié: (2017)